Acylcarnitine Metabolomic Profiles Inform Clinically-Defined Major Depressive Phenotypes
A. T. Ahmed, S. MahmoudianDehkordi, S. Bhattacharyya, M. Arnold, D. Liu, D. Neavin, M. A. Moseley, J. W. Thompson, L. S. J. Williams, G. Louie, M. K. Skime, L. Wang, P. Riva-Posse, W. McDonald, W. V. Bobo, , R. Kaddurah-Daouk
This study identifies distinct acylcarnitine metabolomic profiles associated with different subtypes of major depressive disorder following SSRI treatment.
bioRxiv · May 9, 2019Biochemistry